Kazia Therapeutics (KZIA) Consolidated Net Income (2009 - 2011)

Kazia Therapeutics has reported Consolidated Net Income for 3 years, with the latest figure at -$926122.0 in Q4 2011.

• For the quarter ending Q4 2011, Consolidated Net Income rose 81.99% year-over-year to -$926122.0; the trailing twelve-month figure through Dec 2025 stood at -$0.0 (changed 0.0% YoY), and the FY2025 full-year result was -$13.3 million, up 24.87% from the prior year.
• Consolidated Net Income for Q4 2011 stood at -$926122.0, up from -$5.1 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$926122.0 in Q4 2011, with the low at -$5.8 million in Q4 2009.
• Historically, Consolidated Net Income has averaged -$4.0 million across 3 years, with a median of -$5.1 million in 2010.
• Annual changes were most pronounced in 2010 — Consolidated Net Income gained 11.52% — and 2011, when it surged 81.99%.
• Kazia Therapeutics' Consolidated Net Income stood at -$5.8 million in 2009, then advanced by 11.52% to -$5.1 million in 2010, then surged by 81.99% to -$926122.0 in 2011.
• The last three Consolidated Net Income figures came in at -$926122.0 (Q4 2011), -$5.1 million (Q4 2010), and -$5.8 million (Q4 2009), per Business Quant data.